BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 11514944)

  • 1. Continued occurrence of Accutane-exposed pregnancies.
    Honein MA; Paulozzi LJ; Erickson JD
    Teratology; 2001 Sep; 64(3):142-7. PubMed ID: 11514944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accutane-exposed pregnancies--California, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Jan; 49(2):28-31. PubMed ID: 10680601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.
    Brinker A; Kornegay C; Nourjah P
    Arch Dermatol; 2005 May; 141(5):563-9. PubMed ID: 15897377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pregnancy-prevention program in women of childbearing age receiving isotretinoin.
    Mitchell AA; Van Bennekom CM; Louik C
    N Engl J Med; 1995 Jul; 333(2):101-6. PubMed ID: 7777014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.
    Schaefer C; Meister R; Weber-Schoendorfer C
    Arch Gynecol Obstet; 2010 Feb; 281(2):221-7. PubMed ID: 19444462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of pregnancy after discontinuation of isotretinoin.
    Dai WS; Hsu MA; Itri LM
    Arch Dermatol; 1989 Mar; 125(3):362-5. PubMed ID: 2923442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal exposure to isotretinoin-an international problem.
    Garcia-Bournissen F; Tsur L; Goldstein LH; Staroselsky A; Avner M; Asrar F; Berkovitch M; Straface G; Koren G; De Santis M
    Reprod Toxicol; 2008 Jan; 25(1):124-8. PubMed ID: 18077132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isotretinoin (Roaccutane) in women of childbearing age: failure of following prescription guidelines].
    Autret E; Radal M; Jonville-Béra AP; Goehrs JM
    Ann Dermatol Venereol; 1997; 124(8):518-22. PubMed ID: 9740842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isotretinoin in childbearing women: compliance with strengthen warnings].
    Autret-Leca E; Jonville-Béra AP; Szafir D; Cissoko H; Boulkroun Y; Goehrs JM
    Ann Dermatol Venereol; 2000 Oct; 127(10):808-13. PubMed ID: 11060382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal outcome after in utero exposure to cancer chemotherapy.
    Zemlickis D; Lishner M; Degendorfer P; Panzarella T; Sutcliffe SB; Koren G
    Arch Intern Med; 1992 Mar; 152(3):573-6. PubMed ID: 1546920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective.
    Bérard A; Azoulay L; Koren G; Blais L; Perreault S; Oraichi D
    Br J Clin Pharmacol; 2007 Feb; 63(2):196-205. PubMed ID: 17214828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of pregnant women using isotretinoin.
    Robertson J; Polifka JE; Avner M; Chambers C; Delevan G; Koren G; Lavigne SV; Martinez LP; Miller RK; Carey JC
    Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):881-7. PubMed ID: 16228976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is topical tretinoin safe during the first trimester?
    Shapiro L; Pastuszak A; Curto G; Koren G
    Can Fam Physician; 1998 Mar; 44():495-8. PubMed ID: 9559187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Young women taking isotretinoin still conceive. Role of physicians in preventing disaster.
    Atanackovic G; Koren G
    Can Fam Physician; 1999 Feb; 45():289-92. PubMed ID: 10065298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to ensure fetal safety when mothers use isotretinoin (Accutane).
    Koren G; Pastuszak A
    Can Fam Physician; 1997 Feb; 43():216-9. PubMed ID: 9040906
    [No Abstract]   [Full Text] [Related]  

  • 16. Isotretinoin and pregnancy.
    Stern RS; Rosa F; Baum C
    J Am Acad Dermatol; 1984 May; 10(5 Pt 1):851-4. PubMed ID: 6233342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family physicians and accutane.
    Van Durme DJ
    Am Fam Physician; 2000 Oct; 62(8):1772, 1774, 1777. PubMed ID: 11057835
    [No Abstract]   [Full Text] [Related]  

  • 18. Pregnancy outcomes and factors associated with voluntary pregnancy termination in women who had been treated for acne with isotretinoin.
    Yook JH; Han JY; Choi JS; Ahn HK; Lee SW; Kim MY; Ryu HM; Nava-Ocampo AA
    Clin Toxicol (Phila); 2012 Dec; 50(10):896-901. PubMed ID: 23116253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compliance with pregnancy prevention measures during isotretinoin therapy.
    Collins MK; Moreau JF; Opel D; Swan J; Prevost N; Hastings M; Bimla Schwarz E; Korb Ferris L
    J Am Acad Dermatol; 2014 Jan; 70(1):55-9. PubMed ID: 24157382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy prevention among women taking isotretinoin: failure to comply with the recommendations.
    Boucher N; Beaulac-Baillargeon L
    Can Fam Physician; 2006 Mar; 52(3):338-9. PubMed ID: 16926960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.